Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
Journal of Alcoholism and Drug Dependence
|
August 12, 2016
Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?
Kenneth Blum, Marlene Oscar-Berman, Seth H Blum, et al.
Journal of Behavioral Addictions
|
July 2, 2015
Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy
Thomas McLaughlin, Kenneth Blum, Marlene Oscar-Berman, et al.
Annals of Translational Medicine
|
December 5, 2022
"Preaddiction" construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation
Kenneth Blum, Igor Elman, Catherine A Dennen, et al.
Journal of Systems and Integrative Neuroscience
|
February 10, 2018
Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone?
Thomas McLaughlin, David Han, James Nicholson, et al.
Journal of Systems and Integrative Neuroscience
|
July 25, 2017
Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission
Kenneth Blum, Edward J Modestino, Marcelo Febo, et al.
Substance Use & Misuse
|
December 30, 2016
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)
Kenneth Blum, Marcelo Febo, Lyle Fried, et al.
Clinical Medical Reviews and Case Reports
|
December 8, 2017
Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake
Lucien L Duquette, Frank Mattiace, Kenneth Blum, et al.
Nucleic Acids Research
|
December 31, 2005
PepSeeker: a database of proteome peptide identifications for investigating fragmentation patterns
Thomas McLaughlin, Jennifer A Siepen, Julian Selley, et al.
Journal of Behavioral Addictions
|
January 11, 2018
Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD
Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, et al.
Journal of Reward Deficiency Syndrome and Addiction Science
|
February 18, 2017
KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit?
Thomas McLaughlin, Marcelo Febo, Rajendra D Badgaiyan, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
Journal of Alcoholism and Drug Dependence
|
August 12, 2016
Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?
Kenneth Blum, Marlene Oscar-Berman, Seth H Blum, et al.
Journal of Behavioral Addictions
|
July 2, 2015
Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy
Thomas McLaughlin, Kenneth Blum, Marlene Oscar-Berman, et al.
Annals of Translational Medicine
|
December 5, 2022
"Preaddiction" construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation
Kenneth Blum, Igor Elman, Catherine A Dennen, et al.
Journal of Systems and Integrative Neuroscience
|
February 10, 2018
Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone?
Thomas McLaughlin, David Han, James Nicholson, et al.
Journal of Systems and Integrative Neuroscience
|
July 25, 2017
Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission
Kenneth Blum, Edward J Modestino, Marcelo Febo, et al.
Substance Use & Misuse
|
December 30, 2016
Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS)
Kenneth Blum, Marcelo Febo, Lyle Fried, et al.
Clinical Medical Reviews and Case Reports
|
December 8, 2017
Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake
Lucien L Duquette, Frank Mattiace, Kenneth Blum, et al.
Nucleic Acids Research
|
December 31, 2005
PepSeeker: a database of proteome peptide identifications for investigating fragmentation patterns
Thomas McLaughlin, Jennifer A Siepen, Julian Selley, et al.
Journal of Behavioral Addictions
|
January 11, 2018
Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD
Thomas McLaughlin, Kenneth Blum, Bruce Steinberg, et al.
Journal of Reward Deficiency Syndrome and Addiction Science
|
February 18, 2017
KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit?
Thomas McLaughlin, Marcelo Febo, Rajendra D Badgaiyan, et al.
Page
of 7